Dollar Tree vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 74)

Dollar Tree

LeaderConsumer Goods

Enterprise

Chesapeake VA value retail (NASDAQ: DLTR) at $17.6B FY2024 revenue; Family Dollar sold for $1B (2025, vs. $9.5B acquired 2015), multi-price 3.0 format ($1.25-$7) in 2,900 stores competing with Dollar General for value shoppers.

AI VisibilityBeta
Overall Score
B74
Category Rank
#56 of 290
AI Consensus
50%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
65
Gemini
81

About

Dollar Tree, Inc. is a Chesapeake, Virginia-based discount variety retailer — publicly traded on NASDAQ (NASDAQ: DLTR) as an S&P 500 Consumer Staples component — operating as a Fortune 200 company with approximately 16,000 stores across 48 states and five Canadian provinces through over 214,000 employees, with fiscal year 2024 revenue of $17.6 billion. The company's defining strategic development of 2025 was the completion of the sale of its Family Dollar business to Brigade Capital Management and Macellum Capital Management for just over $1 billion — a $8.5 billion write-down from the original $9.5 billion Family Dollar acquisition price in 2015, marking one of the largest retail acquisition failures in recent history. The divestiture concentrates Dollar Tree on its core namesake banner, which has undergone its own transformation: the company raised prices from $1.00 to $1.25 in 2022 (the first price increase in 36 years of the $1 fixed-price promise) and has expanded approximately 2,900 stores to the multi-price "3.0" format offering products up to $7. Founded in 1986 by Macon Brock and Doug Perry in Norfolk, Virginia as a single-price point variety store, Dollar Tree grew to become the dominant US single-price-point retailer before the ill-fated Family Dollar acquisition transformed it into a dual-banner company trying to serve both the $1-focused impulse buyer and the neighborhood dollar store shopper.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

74
Overall Score
90
#56
Category Rank
#9
50
AI Consensus
60
stable
Trend
stable
83
ChatGPT
99
65
Perplexity
99
81
Gemini
83
83
Claude
96
70
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.